Amanote Research
Register
Sign In
021 Nanoparticle Vaccine of Cervical Cancer Based E7-Hsp110 Activate the Exclusive Killing-Tumor Response of CD8+T Cells in Mice
Journal of Investigative Dermatology
- United Kingdom
doi 10.1016/j.jid.2019.03.097
Full Text
Open PDF
Abstract
Available in
full text
Categories
Biochemistry
Dermatology
Cell Biology
Molecular Biology
Date
May 1, 2019
Authors
Y. Zhang
J. Tang
Publisher
Elsevier BV
Related search
Enhanced Stimulation of Anti-Ovarian Cancer CD8+ T Cells by Dendritic Cells Loaded With Nanoparticle Encapsulated Tumor Antigen
American Journal of Reproductive Immunology
Gynecology
Reproductive Medicine
Immunology
Obstetrics
Allergy
Cancer Vaccines: The Molecular Basis for T Cell Killing of Tumor Cells
Oncologist
Cancer Research
Medicine
Oncology
Suppression of the CD8 T Cell Response by Human Papillomavirus Type 16 E7 Occurs in Langerhans Cell-Depleted Mice
Scientific Reports
Multidisciplinary
Modulating Immunometabolism of Tumor Specific CD8 T Cells to Enhance T Cell Based Therapy for Cancer
Journal for ImmunoTherapy of Cancer
Oncology
Molecular Medicine
Pharmacology
Cancer Research
Allergy
Immunology
Effective Activation of Human Antigen-Presenting Cells and Cytotoxic CD8+ T Cells by a Calcium Phosphate-Based Nanoparticle Vaccine Delivery System
Vaccines
Drug Discovery
Infectious Diseases
Immunology
Pharmacology
Nondominant CD8 T Cells Are Active Players in the Vaccine-Induced Antitumor Immune Response
Journal of Immunology
Allergy
Immunology
Intravaginal TLR Agonists Increase Local Vaccine-Specific CD8 T Cells and Human Papillomavirus-Associated Genital-Tumor Regression in Mice
Mucosal Immunology
Allergy
Immunology
LILRB1 Blockade Enhances Bispecific T Cell Engager Antibody–Induced Tumor Cell Killing by Effector CD8+ T Cells
Journal of Immunology
Allergy
Immunology
CD39 Expression Defines Cell Exhaustion in Tumor-Infiltrating CD8+T Cells—Response
Cancer Research
Cancer Research
Oncology
